AMLX
Amylyx Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$13.98
+0.99 (+7.62%)
Open$13.35
Previous Close$12.99
Day High$14.08
Day Low$13.27
52W High$17.49
52W Low$2.60
Volume—
Avg Volume1.32M
Market Cap1.54B
P/E Ratio—
EPS$-1.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+165.7% upside
Current
$13.98
$13.98
Target
$37.15
$37.15
$28.49
$37.15 avg
$49.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 140.81M | 449.35M | 403.13M |
| Net Income | -486,303,023 | 64.17M | 62.78M |
| Profit Margin | -345.4% | 14.3% | 15.6% |
| EBITDA | -507,728,821 | 107.91M | 96.37M |
| Free Cash Flow | — | 81.20M | 53.03M |
| Rev Growth | +574.3% | +13.9% | +9.9% |
| Debt/Equity | — | 0.29 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |